🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Megan L. Peach

Frederick National Laboratory for Cancer Research

ORCID: 0000-0002-4290-5268
Computer ScienceBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.9Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules

Scientific Data(2020)10.1038/s41597-020-00727-4
Top 9%
2.5DataRank
Top 9%74 citations

Wolf D. Ihlenfeldt, Philip N. Judson, Yurii S. Moroz, Yuri Pevzner, Megan L. Peach +4 more

Papers

Driven by 10 papers — median percentile 79. Top paper: “SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules”.

SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules

Scientific Data(2020)10.1038/s41597-020-00727-4
Top 9%
2.5DataRank
Top 9%74 citations

Wolf D. Ihlenfeldt, Philip N. Judson, Yurii S. Moroz, Yuri Pevzner, Megan L. Peach +4 more

Synthetically Accessible Virtual Inventory (SAVI)

ChemRxiv(2020)10.26434/chemrxiv.12185559.v1
Top 21%
0.959DataRank
Top 21%12 citations

Wolf D. Ihlenfeldt, Philip N. Judson, Yurii S. Moroz, Yuri Pevzner, Megan L. Peach +3 more

Synthetically Accessible Virtual Inventory (SAVI)

ChemRxiv(2020)10.26434/chemrxiv.12185559
Top 44%
0.426DataRank
Top 44%6 citations

Wolf D. Ihlenfeldt, Philip N. Judson, Yurii S. Moroz, Yuri Pevzner, Megan L. Peach +3 more

Design, Synthesis, and Characterization of Novel sn -1 Heterocyclic DAG-Lactones as PKC Activators

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00739
N/A
0DataRank · unranked
9 citations

Ana Bellomo, Mariana Cooke, Antonella Scravaglieri, Larry V. Pearce, Megan L. Peach +4 more

Selective Recognition of Carbohydrate Antigens by Germline Antibodies Isolated from AID Knockout Mice

Journal of the American Chemical Society(2022)10.1021/jacs.1c12745
N/A
0DataRank · unranked
7 citations

Jacey R. Pridgen, Avery Tytla, Megan L. Peach, Rayleen Hu, David W. Farnsworth +6 more

KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma.

Research Square(2022)10.21203/rs.3.rs-2298627/v1
N/A
0DataRank · unranked
0 citations

Berkley E. Gryder, Ranuka Sinniah, Megan L. Peach, Jack F. Shern, Abdalla Abdelmaksoud +26 more

Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs

Molecules(2020)10.3390/molecules25235683
N/A
0DataRank · unranked
23 citations

Shaunna Beedie, Cindy H. Chau, Matthew K. Collins, Suzana Markolovic, Weiming Luo +8 more

KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma

Nature Communications(2024)10.1038/s41467-024-45902-y
N/A
0DataRank · unranked
18 citations

Berkley E. Gryder, Ranuka Sinniah, Megan L. Peach, Jack F. Shern, Abdalla Abdelmaksoud +27 more

Design, Synthesis and Characterization of Novel sn-1 Heterocyclic DAGlactones as PKCe Activators

ChemRxiv(2020)10.26434/chemrxiv.13107194
N/A
0DataRank · unranked
1 citations

Ana Bellomo, Mariana Cooke, Antonella Scravaglieri, Larry V. Pearce, Megan L. Peach +4 more

Design, Synthesis and Characterization of Novel sn-1 Heterocyclic DAGlactones as PKCe Activators

ChemRxiv(2020)10.26434/chemrxiv.13107194.v1
N/A
0DataRank · unranked
1 citations

Ana Bellomo, Mariana Cooke, Antonella Scravaglieri, Larry V. Pearce, Megan L. Peach +4 more